David P. Hochman
See Remarks at Orchestra BioMed Holdings Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Orchestra BioMed Holdings Inc., 3 years.
Orchestra BioMed Holdings Inc.
Director · See Remarks
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −3,283 | $4.02 | $13,198 |
| Jun 10, 2026 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −3,283 | $4.02 | $13,198 |
| Jun 1, 2026 | Orchestra BioMed Holdings Inc. | Open-market purchase | +5,000 | $3.83 | $19,150 |
| May 15, 2026 | Orchestra BioMed Holdings Inc. | Open-market purchase | +5,000 | $3.77 | $18,850 |
| Mar 25, 2026 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −32,438 | $4.57 | $148,242 |
| Mar 13, 2026 | Orchestra BioMed Holdings Inc. | Open-market purchase | +10,000 | $4.29 | $42,900 |
| Feb 12, 2026 | Orchestra BioMed Holdings Inc. | Grant or award | +504,000 | — | — |
| Dec 10, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −40,355 | $4.67 | $188,458 |
| Dec 10, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −3,283 | $4.67 | $15,332 |
| Nov 14, 2025 | Orchestra BioMed Holdings Inc. | Open-market purchase | +5,000 | $4.07 | $20,350 |
| Nov 13, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −3,283 | $4.18 | $13,723 |
| Nov 13, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −3,283 | $4.18 | $13,723 |
| Sep 17, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −40,355 | $2.46 | $99,273 |
| Sep 17, 2025 | Orchestra BioMed Holdings Inc. | Shares withheld for tax | −3,283 | $2.46 | $8,076 |
| Aug 21, 2025 | Orchestra BioMed Holdings Inc. | Open-market purchase | +6,000 | $2.49 | $14,940 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.